FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2298045459> ?p ?o ?g. }

• W2298045459 abstract "The absorption and oral bioavailability of poorly water-soluble drugs is often limited by poor aqueous solubility and slow dissolution in the gastrointestinal (GI) tract. Lipid-based formulations are a popular formulation approach to enhance oral bioavailability for drugs where water solubility is the primary limitation to absorption. The research undertaken in this thesis examines the use of different types and masses of lipids to improve drug solubilisation and absorption, and investigates the contribution of gastric processing to the improvements in oral bioavailability typically seen after co-administration of poorly water-soluble drugs with lipids and lipid-based formulations.A simple in vitro lipid digestion model was used to assess the effect of lipid type and mass on the solubilisation of three model lipophilic drugs (danazol, cinnarizine and halofantrine). Digestion of medium chain triacylglyceride (MCT) formulations yielded improved drug solubilisation (and resulted in drug supersaturation) at high lipid mass (250 mg). In contrast, for long chain triacylglyceride (LCT) formulations, drug concentrations in the aqueous phase of the digests were higher after digestion of the smallest lipid masses, regardless of drug lipophilicity. In all cases, digestion of the LCT formulations was incomplete, resulting in a residual oil phase. At low masses of LCT lipid (50 mg), digestion was more complete, resulting in increased drug transfer into the aqueous phase. For the more lipophilic drugs, partitioning into the residual oil phase increased. Drug lipophilicity, the choice and quantity of lipid, and the need for complete digestion of the formulation were therefore important indicators of the performance of the in vitro lipid digestion assay.Cinnarizine (CZ) was subsequently chosen as a model poorly water-soluble drug to exemplify the effects of lipid load on drug exposure in in vivo studies and to compare in vitro and in vivo performance. In vivo bioavailability studies were undertaken at fixed and varied lipid:CZ ratios and after administration with LCT and MCT. In all cases, the bioavailability of CZ was higher after administration of LCT rather than MCT formulations, regardless of lipid mass. At a fixed lipid:CZ ratio, increasing the quantity of formulation did not affect oral bioavailability, and linear pharmacokinetics were observed. When the lipid:CZ ratio was increased, CZ absorption increased at lipid doses from 50 mg to 250 mg, but did not increase further beyond 250 mg. The data suggest that the type and mass of lipid co-administered are important, but that in most cases, LCT formulations outperform the equivalent MCT formulation.The same lipids were also given by intraduodenal administration as both a lipid solution and as a dispersed lipid formulation, to assess the contribution of gastric processing to oral bioavailability. CZ bioavailability was reduced when either formulation was administered intraduodenally and similar trends were evident for MCT and LCT. The data suggest that gastric and intestinal processing contribute to improved CZ absorption.Finally, aspiration of GI content after formulation administration revealed that the digestion of MCT was more prevalent in the stomach than LCT. Gastric processing may explain the improvements in bioavailability when MCT formulations (both solution and dispersion) were administered orally when compared to intraduodenally. Surprisingly, LCT formulations were seemingly less dependent on gastric processing.In summary, the research described in this thesis highlights the potential utility (and drawbacks) of in vitro lipid digestion models to predict in vivo absorption, and further shows that the mass and type of lipid, and processing in both the stomach and the intestine are important determinants of oral bioavailability from lipid-based formulations." @default.
• W2298045459 created "2016-06-24" @default.
• W2298045459 creator A5035657084 @default.
• W2298045459 date "2013-01-01" @default.
• W2298045459 modified "2023-09-23" @default.
• W2298045459 title "Investigation of formulation variables and physiological processing on the behaviour of lipid-based formulations for poorly water-soluble drugs" @default.
• W2298045459 doi "https://doi.org/10.4225/03/58b4e8147e0eb" @default.
• W2298045459 hasPublicationYear "2013" @default.
• W2298045459 type Work @default.
• W2298045459 sameAs 2298045459 @default.
• W2298045459 citedByCount "0" @default.
• W2298045459 crossrefType "dissertation" @default.
• W2298045459 hasAuthorship W2298045459A5035657084 @default.
• W2298045459 hasConcept C125287762 @default.
• W2298045459 hasConcept C155574463 @default.
• W2298045459 hasConcept C159985019 @default.
• W2298045459 hasConcept C178790620 @default.
• W2298045459 hasConcept C181199279 @default.
• W2298045459 hasConcept C181389837 @default.
• W2298045459 hasConcept C185592680 @default.
• W2298045459 hasConcept C192562407 @default.
• W2298045459 hasConcept C201399114 @default.
• W2298045459 hasConcept C2776078883 @default.
• W2298045459 hasConcept C2779697368 @default.
• W2298045459 hasConcept C2780035454 @default.
• W2298045459 hasConcept C2781357212 @default.
• W2298045459 hasConcept C2910483411 @default.
• W2298045459 hasConcept C43617362 @default.
• W2298045459 hasConcept C55493867 @default.
• W2298045459 hasConcept C71924100 @default.
• W2298045459 hasConcept C77281830 @default.
• W2298045459 hasConcept C98274493 @default.
• W2298045459 hasConceptScore W2298045459C125287762 @default.
• W2298045459 hasConceptScore W2298045459C155574463 @default.
• W2298045459 hasConceptScore W2298045459C159985019 @default.
• W2298045459 hasConceptScore W2298045459C178790620 @default.
• W2298045459 hasConceptScore W2298045459C181199279 @default.
• W2298045459 hasConceptScore W2298045459C181389837 @default.
• W2298045459 hasConceptScore W2298045459C185592680 @default.
• W2298045459 hasConceptScore W2298045459C192562407 @default.
• W2298045459 hasConceptScore W2298045459C201399114 @default.
• W2298045459 hasConceptScore W2298045459C2776078883 @default.
• W2298045459 hasConceptScore W2298045459C2779697368 @default.
• W2298045459 hasConceptScore W2298045459C2780035454 @default.
• W2298045459 hasConceptScore W2298045459C2781357212 @default.
• W2298045459 hasConceptScore W2298045459C2910483411 @default.
• W2298045459 hasConceptScore W2298045459C43617362 @default.
• W2298045459 hasConceptScore W2298045459C55493867 @default.
• W2298045459 hasConceptScore W2298045459C71924100 @default.
• W2298045459 hasConceptScore W2298045459C77281830 @default.
• W2298045459 hasConceptScore W2298045459C98274493 @default.
• W2298045459 hasLocation W22980454591 @default.
• W2298045459 hasOpenAccess W2298045459 @default.
• W2298045459 hasPrimaryLocation W22980454591 @default.
• W2298045459 hasRelatedWork W1557218829 @default.
• W2298045459 hasRelatedWork W1600069174 @default.
• W2298045459 hasRelatedWork W1975893269 @default.
• W2298045459 hasRelatedWork W1984189856 @default.
• W2298045459 hasRelatedWork W1993835469 @default.
• W2298045459 hasRelatedWork W2003026126 @default.
• W2298045459 hasRelatedWork W2033305262 @default.
• W2298045459 hasRelatedWork W2069461779 @default.
• W2298045459 hasRelatedWork W2079495578 @default.
• W2298045459 hasRelatedWork W2083117601 @default.
• W2298045459 hasRelatedWork W2196960871 @default.
• W2298045459 hasRelatedWork W2395328799 @default.
• W2298045459 hasRelatedWork W2500886486 @default.
• W2298045459 hasRelatedWork W2744540870 @default.
• W2298045459 hasRelatedWork W2765658011 @default.
• W2298045459 hasRelatedWork W2782465547 @default.
• W2298045459 hasRelatedWork W2892504489 @default.
• W2298045459 hasRelatedWork W2904301117 @default.
• W2298045459 hasRelatedWork W3010330442 @default.
• W2298045459 hasRelatedWork W3117726898 @default.
• W2298045459 isParatext "false" @default.
• W2298045459 isRetracted "false" @default.
• W2298045459 magId "2298045459" @default.
• W2298045459 workType "dissertation" @default.